Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-02-25. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.
OPTHF stock price ended at $0.25 on 星期三, after rising 0.00%
On the latest trading day Feb 11, 2026, the stock price of OPTHF rose by 0.00%, climbing from $0.25 to $0.25. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.25 and a high of $0.25. Alongside this price increase, trading volume also rose by 13.4K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 22.7K shares were traded, amounting to a market value of approximately --.